MannKind
Commercializes Afrezza, FUROSCIX and V-Go while manufacturing Tyvaso DPI for United Therapeutics.
$3.95
After-hours close0.00 (0.00%)
At close$3.95(−2.71%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.08 | — | — |
| Aug 2026 | −$0.01 | −$0.06 | −700.0% |
| May 2026 | −$0.02 | −$0.05 | −150.0% |
| Feb 2026 | −$0.01 | −$0.05 | −400.0% |
| Nov 2025 | $0.01 | $0.03 | +200.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.08 | — | — | $110.2M | — | — |
| Aug 5, 2026 | −$0.01 | −$0.06 | −700.0% | $108.1M | $109.4M | +1.2% |
| May 6, 2026 | −$0.02 | −$0.05 | −150.0% | $105.4M | $90.2M | −14.4% |
| Feb 26, 2026 | −$0.01 | −$0.05 | −400.0% | $97.6M | $112.0M | +14.7% |
| Nov 5, 2025 | $0.01 | $0.03 | +200.0% | $99.9M | $82.1M | −17.7% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 8, 2025 | ||||||
| Feb 26, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 9, 2023 | ||||||
| Feb 23, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 5, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 9, 2021 | ||||||
| Aug 11, 2021 | ||||||
| May 12, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 6, 2020 | ||||||
| Feb 25, 2020 | ||||||
| Nov 6, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 26, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Aug 2, 2018 | ||||||
| May 9, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 10, 2017 | ||||||
| Mar 16, 2017 | ||||||
| Nov 9, 2016 | ||||||
| Aug 8, 2016 | ||||||
| May 9, 2016 | ||||||
| Mar 14, 2016 | ||||||
| Nov 9, 2015 | ||||||
| Aug 10, 2015 | ||||||